United States · News · The Hill

FDA: Mifepristone review won’t be done until March

Published by The Hill · United States 2 h ago

The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it…

Read the full article on The Hill Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (thehill.com)

Also worth reading

New York Post

Trump says he won't let Iran strike L.A. or San Diego: 'Not going to let that happen'

The New York Times

Europe’s Trade Tensions With China Are Coming to a Head

PBS NewsHour

FDA: Mifepristone review won’t be done until March

Share

Also worth reading

Trent Grisham can’t provide leadoff spark for Yankees with uncertainty looming

Nobel Prize in chemistry set to be awarded in Stockholm

Newly obtained footage shows Iran attack on major U.S. post in Kuwait

Trump says he won't let Iran strike L.A. or San Diego: 'Not going to let that happen'

Europe’s Trade Tensions With China Are Coming to a Head

Student loan borrowers have more time to reduce interest rates. Here's what to know